{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:05:04Z","timestamp":1780538704067,"version":"3.54.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":368,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005972","name":"German Cancer Aid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ymthe.2024.12.035","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T09:15:42Z","timestamp":1736932542000},"page":"2328-2329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The risk of reactivity against healthy tissues: Novel CARs demand testing for overlooked binding properties"],"prefix":"10.1016","volume":"33","author":[{"given":"Astrid","family":"Holzinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4302-3240","authenticated-orcid":false,"given":"Hinrich","family":"Abken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.12.035_bib1","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1182\/blood-2016-01-692046","article-title":"Chimeric antigen receptor T cells targeting Fc \u03bc receptor selectively eliminate CLL cells while sparing healthy B cells","volume":"128","author":"Faitschuk","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.12.035_bib2","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1182\/blood-2008-05-157255","article-title":"Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease","volume":"112","author":"Pallasch","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.12.035_bib3","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.4049\/jimmunol.1100532","article-title":"TOSO, the Fcmicro receptor, is highly expressed on chronic lymphocytic leukemia B cells, internalizes upon IgM binding, shuttles to the lysosome, and is downregulated in response to TLR activation","volume":"187","author":"Vire","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2024.12.035_bib4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood-2007-11-124065","article-title":"SAGE analysis demonstrates increased expression of TOSO contributing to Fas-mediated resistance in CLL","volume":"112","author":"Proto-Siqueira","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.12.035_bib5","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1084\/jem.20091107","article-title":"Identity of the elusive IgM Fc receptor (FcmuR) in humans","volume":"206","author":"Kubagawa","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2024.12.035_bib6","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1016\/j.celrep.2019.02.024","article-title":"Fc\u03bc receptor as a Costimulatory Molecule for T Cells","volume":"26","author":"Meryk","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2024.12.035_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.molmet.2012.08.006","article-title":"TOSO promotes \u03b2-cell proliferation and protects from apoptosis","volume":"1","author":"Dharmadhikari","year":"2012","journal-title":"Mol. Metab."},{"key":"10.1016\/j.ymthe.2024.12.035_bib9","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2312374120","article-title":"Dual-inhibitory domain iCARs improve the efficiency of the AND-NOT gate CAR T strategy","volume":"120","author":"Bangayan","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624008359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624008359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:04:44Z","timestamp":1780535084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624008359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1525001624008359"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.12.035","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The risk of reactivity against healthy tissues: Novel CARs demand testing for overlooked binding properties","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.12.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society of Gene and Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}